{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:52:55Z","timestamp":1790193175740,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Research Council of Norway","award":["231917"],"award-info":[{"award-number":["231917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00216-018-1147-y","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T04:20:43Z","timestamp":1528431643000},"page":"4967-4978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS\/MS"],"prefix":"10.1007","volume":"410","author":[{"given":"Linda","family":"V\u00e5rdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5se Marit Leere","family":"\u00d8iestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Pedersen-Bjergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Gjelstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Leere","family":"\u00d8iestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpba.2015.02.017","volume":"113","author":"K Persona","year":"2015","unstructured":"Persona K, Madej K, Knihnicki P, Piekoszewski W. Analytical methodologies for the determination of benzodiazepines in biological samples. J Pharm Biomed Anal. 2015;113:239\u201364.","journal-title":"J Pharm Biomed Anal"},{"key":"1147_CR2","doi-asserted-by":"crossref","unstructured":"Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: a review. Drug Test Anal. 2017","DOI":"10.1002\/dta.2211"},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.forsciint.2014.03.027","volume":"240","author":"ST Bogstrand","year":"2014","unstructured":"Bogstrand ST, Gjerde H. Which drugs are associated with highest risk for being arrested for driving under the influence? A case\u2013control study. Forensic Sci Int. 2014;240:21\u20138.","journal-title":"Forensic Sci Int"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpba.2016.03.028","volume":"125","author":"L Magrini","year":"2016","unstructured":"Magrini L, Cappiello A, Famiglini G, Palma P. Microextraction by packed sorbent (MEPS)-UHPLC-UV: a simple and efficient method for the determination of five benzodiazepines in an alcoholic beverage. J Pharm Biomed Anal. 2016;125:48\u201353.","journal-title":"J Pharm Biomed Anal"},{"key":"1147_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.talanta.2017.08.010","volume":"176","author":"M \u0160vidrnoch","year":"2018","unstructured":"\u0160vidrnoch M, Bor\u00e1\u0148ov\u00e1 B, Tomkov\u00e1 J, Ondra P, Maier V. Simultaneous determination of designer benzodiazepines in human serum using non-aqueous capillary electrophoresis\u2013tandem mass spectrometry with successive multiple ionic\u2013polymer layer coated capillary. Talanta. 2018;176:69\u201376.","journal-title":"Talanta"},{"issue":"2","key":"1147_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","volume":"31","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Hutter M, Huppertz LM, Ferlaino S, Redlingsh\u00f6fer L, Auw\u00e4rter V. Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicol. 2013;31(2):263\u201371.","journal-title":"Forensic Toxicol"},{"key":"1147_CR7","unstructured":"EMCDDA. European Drug Report 2017: Trends and Developments. 2017. \n                    http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2017\n                    \n                  . Accessed 05.12.17."},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","volume":"1035","author":"MP Bergstrand","year":"2016","unstructured":"Bergstrand MP, Helander A, Beck O. Development and application of a multi-component LC\u2013MS\/MS method for determination of designer benzodiazepines in urine. J Chromatogr B. 2016;1035:104\u201310.","journal-title":"J Chromatogr B"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","volume":"268","author":"G H\u00f8iseth","year":"2016","unstructured":"H\u00f8iseth G, Tuv SS, Karinen R. Blood concentrations of new designer benzodiazepines in forensic cases. Forensic Sci Int. 2016;268:35\u20138.","journal-title":"Forensic Sci Int"},{"key":"1147_CR10","unstructured":"Middelkoop G. Oslo University Hospital, personal communication 2017."},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jchromb.2011.10.033","volume":"883","author":"E Sauve","year":"2012","unstructured":"Sauve E, Lang\u00f8deg\u00e5rd M, Ekeberg D, \u00d8iestad \u00c5M. Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid\u2013liquid extraction and UPLC\u2013MS\/MS. J Chromatogr B. 2012;883:177\u201388.","journal-title":"J Chromatogr B"},{"issue":"5","key":"1147_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/dta.2045","volume":"9","author":"A Valen","year":"2017","unstructured":"Valen A, Leere \u00d8iestad \u00c5M, Strand DH, Skari R, Berg T. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS\/MS. Drug Test Anal. 2017;9(5):808\u201323.","journal-title":"Drug Test Anal"},{"issue":"5","key":"1147_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/ac010747n","volume":"74","author":"WM Mullett","year":"2002","unstructured":"Mullett WM, Pawliszyn J. Direct determination of benzodiazepines in biological fluids by restricted-access solid-phase microextraction. Anal Chem. 2002;74(5):1081\u20137.","journal-title":"Anal Chem"},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jchromb.2014.10.040","volume":"975","author":"AV Bairros de","year":"2015","unstructured":"de Bairros AV, de Almeida RM, Pantale\u00e3o L, Barcellos T, e Silva SM, Yonamine M. Determination of low levels of benzodiazepines and their metabolites in urine by hollow-fiber liquid-phase microextraction (LPME) and gas chromatography\u2013mass spectrometry (GC\u2013MS). J Chromatogr B. 2015;975:24\u201333.","journal-title":"J Chromatogr B"},{"key":"1147_CR15","doi-asserted-by":"crossref","unstructured":"De Boeck M, Dehaen W, Tytgat J, Cuypers E. Ionic liquid-based liquid\u2013liquid microextraction for benzodiazepine analysis in postmortem blood samples. J Forensic Sci. 2018;","DOI":"10.1111\/1556-4029.13778"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.forsciint.2016.12.026","volume":"274","author":"M Boeck De","year":"2017","unstructured":"De Boeck M, Missotten S, Dehaen W, Tytgat J, Cuypers E. Development and validation of a fast ionic liquid-based dispersive liquid\u2013liquid microextraction procedure combined with LC\u2013MS\/MS analysis for the quantification of benzodiazepines and benzodiazepine-like hypnotics in whole blood. Forensic Sci Int. 2017;274:44\u201354.","journal-title":"Forensic Sci Int"},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.microc.2015.05.009","volume":"123","author":"M Fisichella","year":"2015","unstructured":"Fisichella M, Odoardi S, Strano-Rossi S. High-throughput dispersive liquid\/liquid microextraction (DLLME) method for the rapid determination of drugs of abuse, benzodiazepines and other psychotropic medications in blood samples by liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS) and application to forensic cases. Microchem J. 2015;123:33\u201341.","journal-title":"Microchem J"},{"issue":"11","key":"1147_CR18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4155\/bio.13.59","volume":"5","author":"A Gjelstad","year":"2013","unstructured":"Gjelstad A, Rasmussen KE, Parmer MP, Pedersen-Bjergaard S. Parallel artificial liquid membrane extraction: micro-scale liquid\u2013liquid\u2013liquid extraction in the 96-well format. Bioanalysis. 2013;5(11):1377\u201385.","journal-title":"Bioanalysis"},{"key":"1147_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jpba.2016.07.011","volume":"129","author":"KS Ask","year":"2016","unstructured":"Ask KS, Bardakci T, Parmer MP, Halvorsen TG, \u00d8iestad EL, Pedersen-Bjergaard S, et al. Parallel artificial liquid membrane extraction as an efficient tool for removal of phospholipids from human plasma. J Pharm Biomed Anal. 2016;129:229\u201336.","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"1147_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/anatox\/35.5.280","volume":"35","author":"EL \u00d8iestad","year":"2011","unstructured":"\u00d8iestad EL, Johansen U, \u00d8iestad \u00c5ML, Christophersen AS. Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2011;35(5):280\u201393.","journal-title":"J Anal Toxicol"},{"issue":"7","key":"1147_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00216-007-1238-7","volume":"388","author":"OH Drummer","year":"2007","unstructured":"Drummer OH. Requirements for bioanalytical procedures in postmortem toxicology. Anal Bioanal Chem. 2007;388(7):1495\u2013503.","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"1147_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jat\/bks007","volume":"36","author":"LR Sanches","year":"2012","unstructured":"Sanches LR, Seulin SC, Leyton V, Bismara Paranhos BAP, Pasqualucci CA, Munoz DR, et al. Determination of opiates in whole blood and vitreous humor: a study of the matrix effect and an experimental design to optimize conditions for the enzymatic hydrolysis of glucuronides. J Anal Toxicol. 2012;36(3):162\u201370.","journal-title":"J Anal Toxicol"},{"key":"1147_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.chroma.2014.04.020","volume":"1344","author":"T Berg","year":"2014","unstructured":"Berg T, Karlsen M, \u00d8iestad \u00c5ML, Johansen JE, Liu H, Strand DH. Evaluation of 13C-and 2H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography\u2013tandem mass spectrometry. J Chromatogr A. 2014;1344:83\u201390.","journal-title":"J Chromatogr A"},{"key":"1147_CR24","unstructured":"EMA. Guideline on bioanalytical method validation. 2011. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf\n                    \n                  . Accessed 26.04.18."},{"key":"1147_CR25","unstructured":"GTFCH. Requirements for the validation of Anal Methods (Appendix B). 2009. \n                    https:\/\/www.gtfch.org\/cms\/images\/stories\/files\/Appendix%20B%20GTFCh%2020090601.pdf\n                    \n                  . Accessed 26.04.18."},{"issue":"13","key":"1147_CR26","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"B Matuszewski","year":"2003","unstructured":"Matuszewski B, Constanzer M, Chavez-Eng C. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS. Anal Chem. 2003;75(13):3019\u201330.","journal-title":"Anal Chem"},{"key":"1147_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jchromb.2014.09.018","volume":"971","author":"E Eliassen","year":"2014","unstructured":"Eliassen E, Kristoffersen L. Quantitative determination of zopiclone and zolpidem in whole blood by liquid\u2013liquid extraction and UHPLC-MS\/MS. J Chromatogr B. 2014;971:72\u201380.","journal-title":"J Chromatogr B"},{"key":"1147_CR28","unstructured":"Strand DH, Lang\u00f8deg\u00e5rd M, Gaare KI, Amundsen I, Nilsen M, Kristoffersen L. Determination of twelve commonly found compounds in DUI cases in whole blood using fully automated supported liquid extraction and UHPLC-MS\/MS. SOFT-TIAFT, Boca Raton, Florida, USA2018."},{"issue":"8476","key":"1147_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"327","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327(8476):307\u201310.","journal-title":"Lancet"},{"issue":"2","key":"1147_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.11613\/BM.2015.015","volume":"25","author":"D Giavarina","year":"2015","unstructured":"Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25(2):141\u201351.","journal-title":"Biochem Med"},{"key":"1147_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jchromb.2017.02.010","volume":"1048","author":"L V\u00e5rdal","year":"2017","unstructured":"V\u00e5rdal L, Askildsen H-M, Gjelstad A, \u00d8iestad EL, Edvardsen HME, Pedersen-Bjergaard S. Parallel artificial liquid membrane extraction of new psychoactive substances in plasma and whole blood. J Chromatogr B. 2017;1048:77\u201384.","journal-title":"J Chromatogr B"},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.chroma.2012.06.023","volume":"1249","author":"R Verplaetse","year":"2012","unstructured":"Verplaetse R, Cuypers E, Tytgat J. The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood. J Chromatogr A. 2012;1249:147\u201354.","journal-title":"J Chromatogr A"},{"issue":"6","key":"1147_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/jat\/34.6.332","volume":"34","author":"KW Simonsen","year":"2010","unstructured":"Simonsen KW, Hermansson S, Steentoft A, Linnet K. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2010;34(6):332\u201341.","journal-title":"J Anal Toxicol"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-018-1147-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-018-1147-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T23:12:49Z","timestamp":1559949169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-018-1147-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":33,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1007\/s00216-018-1147-y","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]},"assertion":[{"value":"7 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}